Brain-Derived Neurotrophic Factor in Multiple Sclerosis Disability: A Prospective Study.

BDNF brain-derived neurotrophic factor demyelinating disease immunomodulating agents interferons magnetic resonance imaging multiple sclerosis neurologic manifestations teriflunomide

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
29 Feb 2024
Historique:
received: 02 02 2024
revised: 22 02 2024
accepted: 28 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Multiple sclerosis (MS) is a demyelinating central nervous system disease that leads to neurological disability. Brain-derived neurotrophic factors (BDNFs) are neurotrophins involved in neurodegenerative disorders. This study analysed the relationship between serum BDNF, neurological disability and different MS treatments. We included 63 people with MS (PwMS), with relapsing-remitting MS or clinically isolated syndrome, and 16 healthy controls (HCs). We analysed the serum levels of BDNF and MS specific disability tests (Expanded Disability Status Scale, timed 25-foot walk test, nine-hole peg test), at baseline (V0) and after one year of interferon beta1a or teriflunomide treatment (V1). Baseline BDNF values were not different between the PwMS and HCs (

Identifiants

pubmed: 38539631
pii: brainsci14030243
doi: 10.3390/brainsci14030243
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Vitalie Vacaras (V)

Neurology Department, Cluj Emergency County Hospital, 400012 Cluj-Napoca, Romania.
Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Andreea-Cristina Paraschiv (AC)

Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Silvina Iluț (S)

Neurology Department, Cluj Emergency County Hospital, 400012 Cluj-Napoca, Romania.
Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Cristiana Vacaras (C)

Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Cristina Nistor (C)

Neurology Department, Cluj Emergency County Hospital, 400012 Cluj-Napoca, Romania.
Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Gheorghe-Eduard Marin (GE)

Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Andra Maria Schiopu (AM)

Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Dorian-Traian Nistor (DT)

Department of Oncology and Radiotherapy, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Ștefan Cristian Vesa (ȘC)

Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, Iuliu Haţieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Dafin Fior Mureșanu (DF)

Neurology Department, Cluj Emergency County Hospital, 400012 Cluj-Napoca, Romania.
Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Classifications MeSH